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Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disorder of the gas-
trointestinal tract associated with significant morbidity. While IBD occurs in genetically
susceptible individuals, the etiology is multifactorial, involving environmental influences,
intestinal dysbiosis, and altered immune responses. The rising incidence of IBD in indus-
trialized countries and the emergence of IBD in countries with traditionally low prevalence
underscore the importance of environmental influences in the pathobiology of the disease.
Moreover the high incidence of IBD observed in the South Asian immigrant population in
the United Kingdom and Canada further supports the influence of environmental factors.
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INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic relapsing inflam-
matory condition of the gastrointestinal tract that includes both
Crohn’s disease (CD) and ulcerative colitis (UC). Since the iden-
tification of CD by Crohn (1) and UC by various physicians in
the latter half of the nineteenth century, IBD has been increasingly
identified in populations of northern and western Europe, North
America, and Australia (1, 2). More recently IBD has developed
a wider geographic distribution, emerging in populations previ-
ously thought to be at low risk. Two recent comprehensive reviews
of temporal trends in worldwide incidence rates of pediatric and
adult IBD highlight the rising global rates in both children and
adults in both developed and developing nations (3, 4). Fur-
thermore, studies have shown that individuals who migrate from
low prevalent areas (e.g., South Asia) to high prevalent countries
(e.g., Canada and England) are at increased risk for developing
IBD, particularly among first- and second-generation immigrants
highlighting the importance of environmental influences (5–7).
With increasing worldwide prevalence, IBD is becoming a signif-
icant societal burden, as it generally requires lifelong therapy and
monitoring.
Inflammatory bowel disease is a challenging disease as the
etiology remains unclear, the disease severity is variable and unpre-
dictable, and treatment options are still quite limited and focused
on induction and maintenance of remission and not cure. IBD
is considered to be a multifactorial disease arising from the com-
bined effects of genetic susceptibility, environmental influences,
intestinal dysbiosis, and variation of innate and adaptive immune
responses that trigger an inflammatory response. It is believed
that each of these factors play a contributing role in the induction
of disease and influence the disease course, with varying levels
of influence occurring in pediatrics and adults and in different
population groups.
The South Asian immigrant population in the United King-
dom (UK) and in Canada has demonstrated higher rates of IBD
than in the indigenous populations and in the population in their
countries of origin, reinforcing the importance of environmental
influences (7–10). In this article, we review the literature regarding
those factors implicated in the pathogenesis of IBD with particular
attention to the South Asian populations.
INCIDENCE AND PREVALENCE DATA
Epidemiological studies to date examining the South Asian pop-
ulation are limited to single urban regions that include patients
with access to healthcare (11, 12). In India, adult UC prevalence is
reported as 44.3 cases per 100,000 inhabitants and the crude inci-
dence is reported as 6.02 cases per 100,000 inhabitants per year
(11). Comparisons between different countries’ data suggest that
the adult IBD incidence and prevalence is significantly lower in the
South Asian population than in North America or the UK which
has reported prevalence rates of 144–243 cases per 100,000 inhabi-
tants, and incidence rates of 7.9–20.2 cases per 100,000 inhabitants
per year (13–15). Interestingly, small single center studies in Eng-
land suggest that IBD is seen with greater frequency in patients
from South Asia who subsequently migrate to the UK (Table 1)
(8). Similarly in the pediatric IBD population of British Columbia,
Canada, a higher IBD incidence rate has been reported in the South
Asian community than in other ethnicities, including children of
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Table 1 | Characteristics of South Asian immigrant studies.
Study Disease Population Location Years Incidence in South Asian
population (per 100,000)
Incidence in non-South Asian
population (per 100,000)
Pinsk et al. (7) UC and CD Pediatric British Columbia, Canada 1996–2001 15.19 5.19
Fellows et al. (8) CD Adult and Pediatric Derby, UK 1966–1985 4.39 7.47
Probert et al. (9) UC Adult and Pediatric Leicestershire, UK 1972–1980 9.3 3.6
1981–1989 10.8 5.3
Jayanthi et al.
(10)
CD Adult and Pediatric Leicestershire, UK 1972–1980 1.24 3.47
1981–1989 3.1 5.27
Ref. (7) of the total population 84% second generation; 84% of families originating from the Punjab, 79% Sikh, 11% Muslim, 4% Hindu.
Ref. (9) of the total population 78% first generation, all South Asian children with UC born in the UK, annual UC incidence×105 Sikh, Hindu, and Muslim 1972–
80/1981–89: 0/16.5, 13.4/10.8, 4.6/6.2, respectively, Hindus and Sikhs had significantly more UC than Europeans.
Ref. (10) annual CD incidence×105 Sikh, Hindu, and Muslim 1972–80/1981–89: 1.8/3.4, 1.4/2.4, 0.9/5.4, respectively.
Western European descent (Table 1) (7). These studies suggest that
environmental factors are influential in IBD pathogenesis when an
underlying genetic predisposition is present.
ENVIRONMENT
The relationship between the environment and pathogenesis of
IBD remains difficult to define in part due to the effect of con-
founding variables and timing of exposure(s), which likely occurs
during vulnerable periods of development and may precede onset
of the disease by years.
DIET
Immigration to a western country is associated with experiences
that impact significantly on dietary choices. High costs along
with limited accessibility and availability of ingredients used in
the preparation of traditional diets can result in alterations in
the diet (16). Immigrant families also frequently modify their
diet to assimilate with the indigenous population, adopting both
their food choices and eating patterns, referred to as “dietary
acculturation” (16).
Specifically, dietary changes are noticeable in the South Asian
population after emigration to a Western country. The tradi-
tional South Asian diet consists largely of carbohydrate-rich foods
including wheat, rice, sorghum, and pearl millet, with minimal
consumption of fat-rich foods and sugary drinks (17). A low meat,
fish, and dairy diet are influenced both by the countries high lev-
els of poverty, along with religious and cultural beliefs (18). In
contrast, Western countries have exposed the South Asian popu-
lation to a more processed diet with reduced nutritional quality
including foods higher in fats, sugars, and refined carbohydrates.
This had led to decreased intake of healthy foods such and fruits,
vegetables, whole grains, and fiber, resulting in decreased con-
sumption of trace minerals, vitamins, antioxidants, and essential
polyunsaturated fatty acids (PUFA). Fiber intake is important as
it decreases serum lipids, improves glycemic control and has anti-
inflammatory properties (18). A previous Japanese study reported
a more than a twofold increased risk of CD following similar
dietary changes characterized by consumption of diets high in
fats and oils, sugars, sweeteners, and sweets (19). A recent system-
atic review also reported increased risk of developing CD with high
intake of PUFAs, omega-6-fatty acids, saturated fats and meat, and
increased risk of UC with high intake of total fat, PUFAs, omega-6
fatty acids, and meat (20). On the contrary, high intake of fiber
and fruits was negatively associated with CD risk (20).
A few small studies have supported that a dietary change
occurs with immigration to the western world. A Norwegian study
demonstrated that 45% of Pakistani and 63% of Sri Lankan immi-
grants had an increase in meat intake, and 30 and 45%, respectively
reported a decrease in beans and lentils (21). Increased intake of
high fat dairy products has also been observed in Pakistani women
immigrating to Norway, together with increased consumption of
n−6 PUFA and decreased intake of n−3 PUFA (22). South Asian
immigrants were also found to have a decreased intake of n−3
PUFA and an increase in n−6 PUFA consumption (23, 24).
A similar dietary change has been observed in pediatric patients
in the UK in which South Asian immigrants were found to have
higher energy and fat intake and lower carbohydrate intake than
white European children (25). Similarly, the South Asian pediatric
IBD population of British Columbia, Canada was found to have
a diet high in fat, refined sugar, and low in fresh fruits and veg-
etables compared with their parents and grandparents (7). In this
study, 84% of South Asian IBD patients were second-generation
immigrants, reinforcing the link between Westernization of diets
amongst the immigrant populations and the changing incidence
of IBD.
Experimental data support the link between changing dietary
intake of PUFAs and development of IBD in genetically suscep-
tible individuals (26–29). Indeed, increased intake of omega-6-
fatty acids results in increased synthesis and membrane incor-
poration of arachidonic acid (ARA) with the production of
pro-inflammatory mediators, and increased oxidative stress in
n−6 fatty acid rich membranes. In contrast, the n−3 PUFAs
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
partly replace arachidonic acid in cell membranes and reduce
inflammation.
Another dietary shift occurring in the South Asian popula-
tion is a reduction in fermented food consumption. In India,
fermented foods have been an integral component of the diet
for centuries (30). With limited availability to refrigerate foods,
fermentation was a technique developed using lactic acid bacte-
ria to help with food preservation. Consumption of the food and
associated bacteria are believed to alter the composition of the
Frontiers in Pediatrics | Pediatric Gastroenterology and Hepatology November 2013 | Volume 1 | Article 34 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foster and Jacobson Inflammatory bowel disease and environmental influences
intestinal microbiota (31). The bacteria are referred to as probi-
otics, and are defined by the World Health Organization as “live
microorganisms that, when administered in adequate amounts,
confer a health benefit on the consumer.” [FAO/WHO Guidelines
for the evaluation of probiotics in food (London, ON, Canada)
2002, http://www.fao.org/es/ESN/Probio/probio.htm]. Probiotics
are believed to modulate the immune system and improve the
function of the intestinal mucosal barrier (31). The integrity of
this mucosal barrier is thought to play an important role in IBD
pathogenesis (32), and as such the role of probiotics must be con-
sidered, and is an area needing ongoing research. With increased
availability of refrigeration in South Asia, and across industrialized
nations, consumption of fermented foods has likely decreased in
indigenous and immigrant populations, potentially influencing
the IBD prevalence rates in this subgroup.
Breastfeeding is another possible dietary factor that may be
influential in IBD development. A recent meta-analysis analyzed
17 studies addressing the hypothesis that breastfeeding is a pro-
tective factor against IBD noted that the limited data supports the
hypothesis that breastfeeding confers protection, however larger
more well organized studies are needed (33). Developed coun-
tries likely have easier access to infant formulas, and as such may
be a factor in rising rates of IBD in the Western world. A British
study focusing on a group of ethnic minority women, exploring
factors impacting breastfeeding decisions, reported in particular
that women from the South Asian population indicated that bar-
riers to breastfeeding included lack of privacy associated with co-
inhabitation with a large extended family, and grandparental pres-
sure (34). Living situations following emigration may differ from
those in their native country, and as such may account for changes
in both initiation and maintenance of breastfeeding. Indeed, the
Canadian pediatric IBD study reported that 69% of children with
IBD were breast fed (56% for more than 6-months), in contrast to
92% of parents (80% breast fed for more than 6-months) (7). A
confounding variable is the changing maternal dietary fat intake
and the impact on the offspring. The developing fetus and young
breast-fed infant is solely dependent on the mother for an adequate
supply of essential n−6 and n−3 fatty acids. Placental transfer and
secretion of n−6 and n−3 fatty acids into breast milk is variable
and dependent on maternal dietary intake of n−6 and n−3 fatty
acids, which in turn influences plasma membrane phospholipids
and inflammatory potential of the offspring (35–38).
While, dietary studies to date have shown inconsistent findings
and have been limited by study design and sample size, dietary
changes observed in IBD patients in industrialized countries are
strikingly similar to changes observed in immigrant populations
and within South Asia (18) and thus remain an important vari-
able in the pathogenesis and changing incidence of IBD. We can
expect that IBD incidence rates will continue rise in countries
with such dietary shifts. However, large population based-studies
are required both in developed and in developing countries such
as South Asia to provide more conclusive support for the link
between changing diet and rising incidence of IBD.
THE URBAN ENVIRONMENT
Inflammatory bowel disease incidence rates are higher in the more
industrialized regions of North America and Europe, reinforcing
the important influence of the urban environment in contribut-
ing to IBD pathogenesis. A recent large systematic review and meta
analysis of 40 studies showed that living in an urban environment
may increase the risk of development of UC and CD with a pooled
incidence rate ratio (IRR) of 1.17 (95% CI 1.03–1.32) for UC and
1.42 (95% CI 1.26–1.60) for CD (4).
A number of confounding variables must be taken into account,
and as mentioned previously the role of dietary changes needs to
be considered. A cross sectional study in India comparing the diets
of over 6500 individuals living in both urban and rural commu-
nities reported that those living in an urban setting had a higher
caloric intake, and specifically a higher intake of protein, fat, and
carbohydrates (39).
Other considerations associated with urban living include pop-
ulation density, education, lifestyle changes, and exposure to
industrial pollutants (40). To date, studies examining the relation-
ship between air pollution within the urban setting and disease
have primarily focused on its effects on the respiratory and car-
diovascular systems rather than the effects of pollutants on the
intestinal tract. A database study from the UK found that expo-
sure to sulfur dioxide and nitrogen dioxide may increase the risk
of early onset UC and CD, respectively (41). An ecological study
found a strong correlation between total air emissions of criteria
pollutants and hospitalizations in adults with IBD (42). As the
studies have been limited, further investigation is warranted to
increase our understanding of the role of air pollutants in IBD
pathogenesis.
The urban environments typically have improved sanitation
and hygiene practices than a rural setting, likely altering and
restricting exposure to bacteria in early life. Strachan proposed
the “hygiene hypothesis,” suggesting that exposure to common
infections during immune system development help prepare for
immune challenges later in life, reducing the likelihood of develop-
ing immune mediated/inflammatory disease (43). This hypothesis
is consistent with evidence that IBD is more prevalent in areas
of the world with less infections, improved sanitary living con-
ditions, wide spread vaccine and antibiotic use, and clean food
and water (44, 45). Additional research has suggested that lower
rates of IBD may be associated with populations exposed to higher
pathogen burdens, those living on farms, drinking unpasteurized
milk, exposure to household pets, and having a larger family size
(46). However it remains unclear whether this lack of exposure to
pathogens at an early age does result in an inappropriate immune
response and development of IBD in life (47).
When evaluating rural and urban influences on IBD prevalence
the validity of the available data needs to be considered. Most data
collection occurs in cities with larger hospitals where the stud-
ied population has better access to healthcare and the medical
providers may have more exposure and heightened awareness of
a disease. In contrast, the data from rural regions may have more
inaccuracies as IBD may go unrecognized and/or access to medical
care may be limited.
VITAMIN D
Northern communities of Europe and North America have high
rates of vitamin D deficiency correlating with higher rates of IBD
(48). In contrast, lower rates of IBD are observed in those living
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closer to the equator (49). Indeed, one would anticipate that the
South Asian population migrating to the Northern communities
of Europe and North America would be at higher risk of vitamin
D deficiency (49), an additional factor that must be considered to
explain the rising incidence of IBD in this population.
Both adult and pediatric studies demonstrate that IBD patients
are often deficient in vitamin D (50, 51). Moreover, a recent study
in British Columbia, Canada reported that South Asian adult
IBD patients had consistently lower average serum Vitamin D
levels than non-South Asian patients (average 25OH vitamin D
level±SD (nanomoles per liter) South Asian vs. non-South Asian
44.8± 18.1 vs. 66.4± 25.7, respectively) (52).
The link between IBD and vitamin D has been reinforced by
animal models evaluating immune system modulation through
the signaling of vitamin D through its receptor (VDR) (53). The
VDR is expressed on monocytes, macrophages, and leukocytes
(54, 55), dendritic cells (56, 57), activated CD4+ and CD8+ T
cells (58), and intestinal epithelial cells (48). Vitamin D has been
shown to inhibit antigen presenting cell production of IL-12, a
cytokine responsible for T-helper cell development (59), and also
to directly inhibit T-cell activation and proliferation (60). Addi-
tionally, vitamin D has been noted to induce expression of a CD
susceptibility gene NOD2 in monocytic and epithelial cells (48).
Indeed, IBD mouse models that are VDR deficient have poor reg-
ulation of the immune system and impaired intestinal epithelial
barrier integrity resulting in severe gastrointestinal inflammation
(53). Conversely, vitamin D supplementation has shown thera-
peutic benefit, attenuating spontaneous enterocolitis in the IL-10
knock out mouse, and reducing the relapse rate in adult patients
with quiescent CD (61, 62).
GENETICS
Over recent years there have been considerable advancements
toward understanding the role of genetics in IBD. At present, over
160 susceptibility loci/genes for CD and UC have been identified
(63). Genetic factors account for 13.6% of variance in CD and
7.5% for UC (64). Of the identified loci, 110 are common to both
CD and UC, and more loci have been discovered with IBD than any
other complex disease (65). Although identification of these loci
allows a clearer understanding of the disease, the gene products,
function, and their role in pathogenesis remain unclear. To date a
majority of the genetic research has focused on IBD populations
in North America and Northern Europe. A better understanding
of IBD associated genes and genetic variability among different
ethnic groups may advance our understanding of the disease. Con-
sequently, a need for expansion to include other ethnicities, and
their associated IBD genes is an important area of research as it is
anticipated that additional genes likely exist for these populations
including the South Asian population (66).
HELICOBACTER PYLORI
Helicobacter pylori is a bacterial pathogen associated with chronic
active gastritis, peptic ulcer disease, and gastric cancer that can
be eradicated with antimicrobial therapy. A recent meta-analysis
reported that IBD is negatively associated with this infection, sug-
gesting a possible protective benefit of colonization (67). The
bacteria affects T-cell regulatory gene expression, and as a result
induces an anti-inflammatory response (67). As H. pylori is associ-
ated with crowded living conditions and poor sanitary conditions
(68), this suggests a possible protective mechanism in the South
Asian population prior to emigration. Exposure to improved san-
itation and higher rates of antibiotic treatment in their country
of origin and following emigration, associated with reduced rates
of infection and increased rates of eradiation may contribute to
rising IBD rates.
HELMINTHS
The development of IBD has also been linked to reduced expo-
sure to helminths, thought to be involved in immune regulation
of intestinal microflora (69). The effect of helminths is likely due
to their promotion of T-helper 2 cytokines that are protective and
have an anti-inflammatory role (70). Given this mechanism, thera-
peutic benefits of helminths have been investigated. A randomized
control trial reported improvement of disease activity scores fol-
lowing 12 weeks of ingestion of the helminth Trichuris suis (71).
Lower rates of helminth infections are seen in developed countries
that have higher rates of IBD (71), and may contribute to rising
IBD trends as South Asians emigrate to areas with lower parasitic
burdens.
ORAL CONTRACEPTIVES
A meta-analysis assessing the risk of oral contraceptive use with
the etiology of IBD has supported a positive association with the
relative risk increasing for CD with longer medication exposure
time (72). More recently two large prospective cohorts provided
additional support reporting that the risk of CD was increased
with oral contraceptive use (73). These findings are supported
by the potential pro-inflammatory action of estrogens through
effects on antibody production, T-cell function and on prolifer-
ation of monocytes/macrophages (74). In developing countries
hormonal contraceptive therapy was found to be limited by knowl-
edge deficits, limited accessibility, concern over side effects, and
fear of infertility (75). However, higher oral contraceptive ther-
apy use is likely to occur with urbanization and globalization of
the South Asian population in India and following immigration to
industrialized countries in part due to improved healthcare access.
INTESTINAL MICROBIOTA
There is increasing evidence of a bidirectional interaction between
the host’s intestinal microflora, the intestinal epithelium, and
mucosal immune system. The presence of a highly diverse and
robust intestinal microbial ecosystem is associated with a healthy
intestinal epithelial barrier and appropriately responsive mucosal
immune system. In IBD, patient studies have demonstrated
increased number of mucosal bacteria with a less diversified
intestinal flora (76, 77). Animal models using Interleukin 10 defi-
cient mice have also supported a role for intestinal microbiota in
the pathogenesis of IBD (78–80).
Increased exposure to antibiotics alters the intestinal microflora
(81). One study, evaluating 36 children with IBD compared to
controls reported that antibiotic use was more common in the
first year of life in those children with IBD (58%) than controls
(39%) (82). Similarly, an adult study found higher rates of antibi-
otic use 2–5 years prior to diagnosis of IBD (83). Research within
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this area has been limited due to the difficulty in demonstrating
a clear causal relationship as a result of the various confounding
variables. However, increased antibiotic use has occurred in indus-
trialized nations and likely occurs with urbanization and following
emigration of South Asians to more developed countries.
Secondly, recent studies suggest that variation in intestinal
microbiota is influenced by diet (84, 85). A comparison of the
intestinal microbiota of children from Europe on a westernized
diet, and children from rural Africa on a high fiber diet has shown
differences suggesting that diet impacts gut microbiota (86). For
example, diets high in protein and saturated fats were associated
with Bacteroides in the intestinal microflora, while those high in
carbohydrates and simple sugars were associated with Prevotella
(87). Microbes in our diet have also been shown to affect our
intestinal flora through horizontal transfer of genes encoding spe-
cific carbohydrate degrading enzymes (88). This demonstrates
compensatory adaptation of our intestinal flora to catabolize new
dietary carbohydrates (88).
Thirdly, enteric infections modulate the intestinal commen-
sal microorganisms. Recent studies in mouse models showed that
during Salmonella-induced gastroenteritis the population of com-
mensal flora was reduced (89). This change in the flora resulted
in the accumulation of metabolites such as sugars, that are usually
metabolized by the microbiota (89).
Hence exposure to different diets, increased use of antibiotics
and exposure to new enteric pathogens following urbanization and
globalization and through emigration likely has modifying effects
on the host commensal microbiota and through these actions may
contribute to the rising incidence of IBD.
SUMMARY
While it is believed that the IBD rates in South Asia are rising
and following a similar trend to that observed in the Western
world 50 years ago, it is currently difficult to provide clear evi-
dence, as the data is limited. This is confounded by cases of
IBD in South Asia that may have been previously misclassified
as infectious in etiology. Furthermore increasing awareness and
knowledge of IBD in South Asia associated with increased access
to health care will further complicate determination of incidence.
Conversely, studies in the UK and Canada suggest that following
immigration, the South Asian immigrant population and particu-
larly the immigrant Sikh population is a risk. Plausible risk factors
include changes in diet, environmental exposures, and changes in
intestinal flora. Further studies in these areas are required, both
in the countries of origin and in the countries that these groups
migrate to.
FUTURE DIRECTIONS
Further research comparing trends between developing and devel-
oped countries needs to be undertaken to gain more insight into
the role of environmental factors in the pathogenesis of IBD. More
specifically, studying the effects of urbanization and migration will
likely help increase our understanding of the interactions between
genetics, the environment, and the disease. Moreover, better cate-
gorization of our patients based on understanding the complicated
mix of past and present environmental factors, with population
specific genetic variations, may indeed lead us on a path to better
understanding of disease pathogenesis and targeted therapeutic
approaches in the future.
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